Medikit Co.,Ltd. (TYO:7749)
2,662.00
+86.00 (3.34%)
Mar 10, 2025, 3:30 PM JST
Medikit Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 20,272 | 23,611 | 27,592 | 28,118 | 27,491 | 26,832 | Upgrade
|
Cash & Short-Term Investments | 20,272 | 23,611 | 27,592 | 28,118 | 27,491 | 26,832 | Upgrade
|
Cash Growth | -26.18% | -14.43% | -1.87% | 2.28% | 2.46% | 5.04% | Upgrade
|
Receivables | 5,718 | 5,285 | 5,691 | 5,004 | 4,874 | 4,810 | Upgrade
|
Inventory | 4,149 | 3,877 | 3,281 | 3,626 | 3,699 | 3,693 | Upgrade
|
Restricted Cash | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | Upgrade
|
Other Current Assets | 315 | 218 | 112 | 293 | 60 | 107 | Upgrade
|
Total Current Assets | 31,954 | 34,491 | 38,176 | 38,541 | 37,624 | 36,942 | Upgrade
|
Property, Plant & Equipment | 13,463 | 11,474 | 10,438 | 10,834 | 10,052 | 9,688 | Upgrade
|
Long-Term Investments | 1,099 | 1,248 | 1,077 | 1,136 | 1,180 | 1,059 | Upgrade
|
Goodwill | 2,174 | 2,337 | 1,935 | - | - | - | Upgrade
|
Other Intangible Assets | 1,160 | 1,138 | 1,157 | 126 | 246 | 387 | Upgrade
|
Long-Term Deferred Tax Assets | 188 | 310 | 402 | 419 | 816 | 945 | Upgrade
|
Other Long-Term Assets | - | 1 | 1 | 1 | 2 | 2 | Upgrade
|
Total Assets | 50,038 | 50,999 | 53,186 | 51,057 | 49,920 | 49,023 | Upgrade
|
Accounts Payable | 2,736 | 3,180 | 2,545 | 2,575 | 2,276 | 2,446 | Upgrade
|
Accrued Expenses | 211 | 412 | 413 | 397 | 410 | 435 | Upgrade
|
Current Income Taxes Payable | 658 | 897 | 765 | 604 | 451 | 748 | Upgrade
|
Other Current Liabilities | 1,110 | 1,229 | 950 | 838 | 1,017 | 872 | Upgrade
|
Total Current Liabilities | 4,715 | 5,718 | 4,673 | 4,414 | 4,154 | 4,501 | Upgrade
|
Long-Term Deferred Tax Liabilities | 336 | 336 | 330 | - | - | - | Upgrade
|
Other Long-Term Liabilities | 827 | 817 | 806 | 788 | 1,991 | 2,005 | Upgrade
|
Total Liabilities | 5,878 | 6,871 | 5,895 | 5,286 | 6,285 | 6,855 | Upgrade
|
Common Stock | 1,241 | 1,241 | 1,241 | 1,241 | 1,241 | 1,241 | Upgrade
|
Additional Paid-In Capital | 8,446 | 8,432 | 10,384 | 10,378 | 10,378 | 10,378 | Upgrade
|
Retained Earnings | 40,438 | 39,826 | 38,519 | 37,165 | 35,012 | 33,201 | Upgrade
|
Treasury Stock | -6,552 | -6,046 | -3,243 | -3,256 | -3,190 | -2,743 | Upgrade
|
Comprehensive Income & Other | 587 | 675 | 390 | 243 | 194 | 91 | Upgrade
|
Shareholders' Equity | 44,160 | 44,128 | 47,291 | 45,771 | 43,635 | 42,168 | Upgrade
|
Total Liabilities & Equity | 50,038 | 50,999 | 53,186 | 51,057 | 49,920 | 49,023 | Upgrade
|
Net Cash (Debt) | 20,272 | 23,611 | 27,592 | 28,118 | 27,491 | 26,832 | Upgrade
|
Net Cash Growth | -26.18% | -14.43% | -1.87% | 2.28% | 2.46% | 5.04% | Upgrade
|
Net Cash Per Share | 1368.63 | 1445.78 | 1643.95 | 1673.59 | 1626.98 | 1582.54 | Upgrade
|
Filing Date Shares Outstanding | 14.62 | 14.8 | 16.79 | 16.78 | 16.81 | 16.96 | Upgrade
|
Total Common Shares Outstanding | 14.62 | 14.8 | 16.79 | 16.78 | 16.81 | 16.96 | Upgrade
|
Working Capital | 27,239 | 28,773 | 33,503 | 34,127 | 33,470 | 32,441 | Upgrade
|
Book Value Per Share | 3020.11 | 2982.53 | 2817.14 | 2727.96 | 2596.51 | 2487.01 | Upgrade
|
Tangible Book Value | 40,826 | 40,653 | 44,199 | 45,645 | 43,389 | 41,781 | Upgrade
|
Tangible Book Value Per Share | 2792.09 | 2747.66 | 2632.95 | 2720.45 | 2581.87 | 2464.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.